Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity.

Johannes Sam,Sara Colombetti,Tanja Fauti,Andreas Roller,Marlene Biehl,Linda Fahrni,Valeria Nicolini,Mario Perro,Tapan Nayak,Esther Bommer,Anne Schoenle,Maria Karagianni,Marine Le Clech,Nathalie Steinhoff,Christian Klein,Pablo Umaña,Marina Bacac

FRONTIERS IN ONCOLOGY（2021）

引用 26|浏览28

暂无评分

摘要

[This corrects the article .].

查看译文

关键词

T-cell bispecific antibody,carcinoembryonic antigen T-cell bispecific antibody,combination,humanized mice,immunotherapy,programmed death–ligand 1,solid tumors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要